Facteurs De Risques De Récidive D'épistaxis Chez L'adulte
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 145
- 试验地点
- 1
- 主要终点
- Survival without bleeding
研究概览
简要总结
We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied.
The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test.
详细描述
We study all patients admitted to the Emergency Department in the Institution between 01/2022 and 07/2023. The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information. Thus, several potentiel risk factors were studied : oral anticoagulants, sex, INR, anti-platelets drugs, diabetes, obesity, arterial hypertension, heart failure, hemoglobin at the admission, history of chronic rhinosinusitis, appointment with an ENT during the acute bleeding, sleep apnea, age, anatomic abnormality, recent surgery within 2 months, previous admission within 30 days in the emergency department, nasal trauma.
The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test.
This study aim to provide a pronostic score of recurrence that can happen after the 3 fisrt weeks after the event. When a recurrence happens before 3 weeks, this was considered to be a non control of the bleeding episode.
This score will be then tested on our cohort to evaluate specificity and sensibility.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient who is admitted at the emergency department between 01/2022 and 07/2023 for nose bleeding.
- •Age over 18 yo
排除标准
- •Opposition to be included
- •Patient who has not his willness to provide opposition to participate.opposition
结局指标
主要结局
Survival without bleeding
时间窗: 1 year
Measuring the delay between the first epistaxis and a recurrence.
次要结局
未报告次要终点
